55直播体育
55直播体育:About Henlius
Company Profile
55直播体育:Corporate Culture
Honor
55直播体育:Board of Directors
Management Team
55直播体育:Advisory Committee
Product
55直播体育:Marketed Products
55直播体育:Products in R&D
55直播体育:Clinical Trial
55直播体育:Science & Technology
R&D Result
Innovation Centre
Technology Platform
Quality Management
55直播体育:Manufacturing
55直播体育:Collaborations
Investor Relations
Information Disclosure
55直播体育:Corporate Governance
55直播体育:Financial Reports
55直播体育:Stock Info
55直播体育:IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
Multi-media
Media Reports
Media Enquiry
Careers
55直播体育:Talent Philosophy
Staff Life
55直播体育:Training and Development
55直播体育:Contact Us
55直播体育:Contact Information
55直播体育:Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
55直播体育:About Henlius
Company Profile
55直播体育:Corporate Culture
Honor
55直播体育:Board of Directors
Management Team
55直播体育:Advisory Committee
Product
55直播体育:Marketed Products
55直播体育:Products in R&D
Clinical Trial
55直播体育:Science & Technology
R&D Result
Innovation Centre
55直播体育:Technology Platform
Quality Management
55直播体育:Manufacturing
55直播体育:Collaborations
Investor Relations
Information Disclosure
55直播体育:Listing Documents
Announcement & Circulars
55直播体育:Corporate Governance
Financial Reports
Stock Info
55直播体育:IR Calendar
55直播体育:Investor Presentation
55直播体育:Analyst Coverage
55直播体育:Contact Information
Media
Press Release
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Event
Popular Science
Media Reports
Media Enquiry
Careers
55直播体育:Talent Philosophy
55直播体育:Staff Life
Training and Development
55直播体育:Job Opportunities
Contact Us
Contact Information
55直播体育:Customer Message
Privacy
Legal Statement
55直播体育:Compliance
Be the most trusted biotech company
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
55直播体育:Popular Science
Highlights
Download
Media Reports
55直播体育:Media Enquiry
2024-03-04
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development
2024-02-29
Henlius Adalimumab Biosimilar Received sNDA Acceptance Notification from the NMPA
2024-02-19
ASTRUM-004 Featured on the Cover of Cancer Cell
2024-02-01
Henlius Announces Successful Completion of Phase 1 PK Similarity Clinical Study of Denosumab HLX14
2024-01-25
First International Shipment of HANSIZHUANG
2024-01-17
Results from Clinical Trials of Two Henlius’ Novel Products Released at ASCO GI 2024
2024-01-11
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
2024-01-05
Cancer Cell Published the Results of ASTRUM-004: HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC
2024-01-03
Henlius to Release Clinical Data at 2024 ASCO GI
1
2
3
...
31
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
55直播体育高清 - 55直播nba - 55体育直播
55直播 - 55直播nba高清 - 55足球直播网 - 55体育直播
55世纪 - 官网
55世纪 - 55世纪app - 官网登录
55世纪|55世纪平台|app下载